This post was written by Katherine Yang, Amy Yin, Vicki Lung, Gordon B. Schatz, Jay J. Yan, John J. Tan, Mao Rong and May Wong.
Reed Smith’s China Life Sciences and Health Industry Client Briefing provides a summary of the monthly news and legal developments relating to China’s Pharmaceutical, Medical Device, and Life Sciences/ Health Care Industries.
- Approval of Innovative Drugs and Key Sector Generic Drugs to be Expedited
- Guangzhou Pharma Case
- Fosun Pharma to Acquire Israel-Based Medical Device Manufacturer
- Beijing Hosts Traditional Chinese Medicine (“TCM”) Training Program
- Ministry of Industry and Information Technology (“MIIT”) Supports Development of Medical Devices
- Changes in the Healthcare Industry
- Medical Reforms in China Attract Pharma Giants
- State Council Issues Guiding Opinions on the Reform and Improvement of Local Food and Drug Supervision and Management
- Healthcare Companies Promote Internet-Based Medical Services
To read the full briefing by Reed Smith China team members, click here.
